Phase 1 (2024): Molecular docking and multi-omics integration
Phase 2 (2025): Real-time patient monitoring and early detection
Phase 3 (2026): Adaptive clinical trials and personalized therapeutics
Phase 4 (2027): Full disease prediction and prevention system
Phase 5 (2028): Comprehensive aging reversal and longevity platform
